SymphoRNA
SymphoRNA develops therapies that tackle complex diseases by targeting multiple biological pathways. They use a polysaccharide-based, non-PEG RNA delivery system to carry mRNA, saRNA, and siRNA. The platform combines AI-driven design with programmable RNA cocktails to tune pathways. This category represents a biotech engine delivering therapies to pharma and biotech partners. They are building a broader pipeline across fibrotic, inflammatory, and aging-related diseases.
SymphoRNA
SymphoRNA develops therapies that tackle complex diseases by targeting multiple biological pathways. They use a polysaccharide-based, non-PEG RNA delivery system to carry mRNA, saRNA, and siRNA. The platform combines AI-driven design with programmable RNA cocktails to tune pathways. This category represents a biotech engine delivering therapies to pharma and biotech partners. They are building a broader pipeline across fibrotic, inflammatory, and aging-related diseases.